Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Protective Group Free Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101674835A reveals a streamlined synthesis for Galantamine intermediate C2, offering significant cost reduction and improved purity for API manufacturing supply chains.
Patent CN102115486B reveals a two-step Aramchol synthesis route reducing costs and improving supply chain reliability for global pharmaceutical intermediates manufacturers.